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Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis that most commonly 
affects the lungs. However, extrapulmonary manifestations of TB can affect the eye and surrounding orbital 
tissues. TB can affect nearly any tissue in the eye, and a high index of suspicion is required for accurate di- 
agnosis. Systemic anti-tuberculosis treatment is required in cases of ocular TB, and steroids are sometimes 
necessary to prevent tissue damage secondary to inﬂammation. Delays in diagnosis are common and can 
result in morbidities such as loss of an affected eye. It is important for ophthalmologists and infectious dis- 
ease specialists to work together to accurately diagnose and treat ocular TB in order to prevent vision loss. 
This article reports the various known presentations of orbital and external ocular TB and reviews important 
elements of diagnosis and treatment. 
© 2016 The Authors. Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). 
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Background 
Tuberculosis (TB) is an infectious disease caused by the obligate
aerobic, acid-fast bacillus Mycobacterium tuberculosis [1] . Transmis-
sion is airborne, and the lungs are the most commonly affected organ
[2,3] . However, there are many forms of extrapulmonary tuberculo-
sis, including several varieties that affect the eye [4] . This review will
focus on orbital and external ocular manifestations of TB. 
Literature search strategy 
The literature was reviewed using a PubMed search with both
Medical Subject Headings (MeSH) and keywords. MeSH terms
included tuberculosis, ocular tuberculosis, orbital tuberculosis, eye
infections and visual acuity. Keywords included eye, periocular,
ocular, eyelid, conjunctiva, cornea, lacrimal gland, tuberculosis, “oc-
ular tuberculosis,” and “orbital tuberculosis.” Results were limited
to available peer-reviewed, English-language journals published be-
tween 1930 and 2015. All papers were reviewed, including single case
reports. ∗ Corresponding author. Tel.: 507-284-3726 
E-mail addresses: Dalvin.lauren@mayo.edu (L.A. Dalvin), Smith.Wendy1@mayo.edu 
(W.M. Smith). 
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2405-5794/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article undepidemiology and pathophysiology 
According to the Centers for Disease Control and Prevention
CDC), approximately one third of the world’s population is infected
ith TB. However, only 10% of those infected will develop clinical
anifestations of the disease [5] . Of these, 16–27% have extrapul-
onary manifestations, which includes those with orbital and ex-
ernal eye disease [6] . The precise incidence of ocular TB is much
ore diﬃcult to discern, ranging from 1.4% to 18% in various studies
4,7–12] . Risk factors for extrapulmonary TB include age over
0 years, female gender, and HIV infection [4] . Hematogenous spread
rom the lungs is the primary mechanism by which TB affects the or-
it and eyes, but TB can also spread via direct local extension [13–15] .
 hypersensitivity response from infection elsewhere in the body can
ffect the eyes and surrounding tissues as well [13] . 
xternal ocular involvement 
TB can affect the orbit and external eyes in a wide variety of ways,
hich are summarized in Table 1 . 
rbit 
TB involvement of the orbit can present as proptosis secondary
o mass effect ( Fig. 1 ) or diplopia from cranial nerve or extraocu-
ar muscle involvement [16] . Orbital involvement is usually unilateral
nd is more common in children, but cases have also been reported
n adults [17,18] . Numerous pediatric cases of draining sinus tractsr the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). 
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Fig. 1. Orbital tuberculosis presenting as proptosis. (A) Caldwell view x-ray shows bony destruction of the greater wing of the sphenoid (arrow). (B) B-scan ultrasonography reveals 
a retroorbital hypoechoic area in the extraconal space (arrow). (C) Axial contrast-enhanced CT demonstrates left-sided proptosis, lacrimal abscess (arrow), and preseptal thickening 
(arrowhead). (D) Coronal, contrast-enhanced CT scan further illustrates destruction of the greater wing of the sphenoid (arrow) and intracranial extension (arrowhead) [18] . 
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Fig. 2. Orbital tuberculosis with cranial extension and extradural abscess formation. (A) Caldwell view x-ray shows loss of deﬁnition of the greater wing of the sphenoid (arrow). 
(B–D) Axial (B) and coronal (C, D) contrast-enhanced CT scans reveal a right-sided extraconal and lacrimal abscess (asterisk in B, C), an intracranial extradural abscess (arrowhead), 
and an abscess in the infratemporal fossa region (double arrowhead). (C, D) Irregularity and sclerosis of the sphenoid and zygomatic bones (arrow) is also seen [18] . 
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band radiographically-conﬁrmed bony changes have been reported
[19–21] . Involvement of the frontal, sphenoid, and zygomatic bones
has been reported [17–19] . Boney involvement can be in the form
of a tuberculous periostitis that typically affects the outer margin of
the orbit, or it can manifest as cortical irregularities that later evolve
into thickening and sclerosis of the orbital bones in longstandingases [18,22] . Extension of orbital tuberculosis into the cranium with
xtradural abscess formation can occur if the condition is allowed
o progress ( Fig. 2 ) [18,23–25] . Caseating granulomas, soft tissue
uberculomas, and diffuse orbital involvement can also occur in both
hildren and adults [20,26,27] . Finally, orbital apex syndrome has
een reported, which can lead to severe vision loss [28] . 
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Fig. 3. Tuberculosis involvement of the lacrimal gland. (A) Axial contrast-enhanced CT scan shows a left lacrimal abscess (asterisk). (B, C) Coronal CT scans reveal irregularity, 
destruction, thickening, and sclerosis of the adjacent frontal and zygomatic bones (arrow) [18] . 
Table 1 
Clinical presentations of external ocular tuberculosis. 
Tissue Possible presentations 
Orbit Periostitis 
Soft tissue tuberculoma 
Bony destruction 
Orbital apex syndrome 
Lacrimal gland Dacryoadenitis 
Abscess 
Eyelid Chronic blepharitis 
Recurrent chalazion 
Diffuse inﬁltration resembling cellulitis 
Conjunctiva Conjunctivitis 
Subconjunctival nodules 
Polyps 
Tuberculomas 
Ulcers 
Phlyctenulosis 
Sclera Nodular anterior scleritis 
Diffuse anterior scleritis 
Scleromalacia 
Sclerokeratitis 
Sclerouveitis 
Posterior scleritis 
Cornea Interstitial keratitis 
Disciform keratitis 
Phlyctenulosis 
Corneal erosions 
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The lacrimal gland can be affected in the form of dacryoadenitis
29] . The clinical presentation can be indistinguishable from bacterial
acryoadenitis, necessitating a high index of suspicion especially in
ases that fail to respond to antibiotics [30] . Abscess formation can
lso occur ( Fig. 3 ) [18] . Biopsy in these cases may reveal caseating
ranulomas [31] . 
yelid 
TB in the eyelid can manifest as chronic blepharitis or nodules re-
embling chalazia, which recur after excision ( Fig. 4 ) [32–36] . Four
uch cases have been reported in the literature. Two cases were uni-
ateral without evidence of systemic disease, and two cases were bi-
ateral with associated pulmonary TB [32–35] . Biopsy in such casesay reveal acid-fast bacteria, but caseating granulomas may be ab-
ent [35] . 
TB can also involve the eyelid secondary to extension of cutaneous
nvolvement, which can manifest as subepithelial nodules, plaques,
r ulcers [37] . Diffuse inﬁltration of the eyelid resembling celluli-
is has also been reported with a paradoxical worsening in response
o typical TB treatment, which ultimately required systemic steroids
38] . 
onjunctiva 
Conjunctival TB may present as conjunctivitis, subconjunctival
odules, polyps, tuberculomas, or ulcers ( Figs. 5 and 6 ) [39–47] .
hile conjunctival involvement is more common in the setting of
ystemic disease, isolated conjunctivitis without systemic ﬁndings
as been reported [48] . Phlyctenulosis can also occur as a hypersensi-
ivity reaction that is not necessarily associated with active infection
49] . 
clera 
Scleritis and scleral nodules have been reported as ocular mani-
estations of TB ( Figs. 7 and 8 ) [50–53] . In fact, a previous study re-
orted that TB was the causative agent in 10.6% of cases of infectious
cleritis [31,54] . Scleritis is usually anterior, but posterior scleritis sec-
ndary to TB has been described [54,55] . Scleritis can be local or dif-
use, but most cases are nodular [31,56] . Lesions can also undergo
ecrosis, leading to scleral thinning [31,56] . Spontaneous perforation
ue to necrotizing scleritis has been reported and may require enu-
leation [57] . Although scleral nodules have been hypothesized to
epresent an exaggerated immune response to TB elsewhere, direct
nfection has been proven in some cases, and pathological study has
uggested that perforation occurs as a result of longstanding infection
52,53,55,57,58] . Scleritis may be associated with adjacent keratitis
r uveitis [31] . TB can also affect the episclera in the form of nodular
piscleritis [59] . 
ornea 
Patients with corneal involvement can present with pain and pho-
ophobia, with exam ﬁndings consistent with deep stromal keratitis
nd corneal erosions [15,60] . Patients can also develop interstitial
eratitis, disciform keratitis, and phlyctenular keratoconjunctivitis 
ue to the body’s immune response to the Mycobacterium [13,61,62] .
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Fig. 4. Eyelid involvement of tuberculosis. (A) Left lower eyelid wound with sub- 
mandibular lymphadenitis in a patient with swollen, erythematous left lower eyelid 
with delayed eyelid wound healing after 1 week of incision and curettage for presumed 
chalazion. (B) Fluctuant, tender submandibular swelling (arrowhead, marked) in the 
same patient that developed 1 week after the photograph in A was taken [35] . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
f  
t  
[
P
 
c  
t  
P  
a
M
 
ﬁ  
d  
(  
t  
t  
n  
g  
h  
h  
l  
w  
d  
h  
t  
h  
p  
S  
n
I
 
t  
o  
u  
f  
c  
o  
d  
t  
i  
u  
w  Diagnosis 
Diagnosis of ocular TB can be very diﬃcult, as it can affect almost
any part of the eye, and the clinical ﬁndings mimic those of a wide
array of different underlying diseases, necessitating a complete
workup to exclude other causes. Delays in diagnosis and initiation of
appropriate ATT are common and may lead to signiﬁcant vision loss
or even loss of the eye [57] . Accurate diagnosis requires a high index
of suspicion, review of associated systemic signs and symptoms, and
appropriate laboratory testing. While there are no clearly deﬁned
criteria for the diagnosis of ocular TB, there are several factors that
can support the diagnosis [13,63] . 
Clinical signs 
As discussed above, TB can manifest in a wide variety of ways in
the orbit and external eye. In particular, TB should be suspected in the
setting of multiple recurrences despite steroids or antibiotics. 
Acid-fast bacteria and histology 
Acid-fast bacteria can sometimes be demonstrated via microscopy
or Lowenstein-Jensen media culture of intraocular ﬂuids or biopsied
tissue, but yield is low [13,14] . A Ziehl–Neelsen stain may reveal acid-Fig. 5. Lymphadenopathy and conjunctivitis caused by direct inoculation with M. tuberculosis
[85] . ast bacilli ( Fig. 9 ), particularly in areas of caseous necrosis; the necro-
izing granulomas themselves are also an important indication of TB
8,64] . 
olymerase chain reaction 
Polymerase chain reaction ampliﬁcation of mycobacterial DNA
an be particularly useful in ocular TB, where the sample size may be
oo small to detect the bacteria on microscopy or culture [47,64,65] .
CR is highly sensitive and speciﬁc and can be useful in the early di-
gnosis of ocular TB [14,64,66–68] . 
antoux skin test 
A Mantoux skin test involves the intradermal injection of a puri-
ed protein derivative, followed by skin examination for cutaneous
elayed-type hypersensitivity reaction 48–72 h after the injection
 Fig. 10 ) [69] . The test is considered positive if the amount of indura-
ion measures greater than 5 mm in an HIV-positive patient, greater
han 10 mm in high-risk persons, including healthcare workers,
ursing home patients, and those living in endemic areas, and
reater than 15 mm for all others [5] . In a rabbit model, cutaneous
ypersensitivity has been shown to correlate directly with ocular
ypersensitivity [70] . Unfortunately, this is a subjective test with
ow sensitivity and speciﬁcity [5] . Some patients, especially those
ho are immunocompromised, may have anergy to the protein and
isplay no reaction, leading to false negative results [5] . Patients who
ave previously received Bacillus Calmette–Guerin (BCG) vaccina-
ions, have been exposed to different species of mycobacteria, or who
ave received multiple Mantoux tests in the past, may have false
ositive reactions [5,13] . However, the United States Preventative
ervices Task Force notes that induration greater than 10 mm should
ot be attributed to prior BCG vaccination [71] . 
nterferon gamma testing 
The QuantiFERON TB-Gold test (QFTG:Cellestis Ltd., Carnegie, Aus-
ralia) is a blood test that detects TB and does not require a return
ﬃce visit (versus the Mantoux skin test.) [72] This test speciﬁcally
ses M. tuberculosis antigens to stimulate interferon gamma release
rom sensitized T cells in infected patients. The M. tuberculosis spe-
iﬁc antigens used in this test will not yield false positive results for
ther mycobacteria or prior BCG vaccination [72,73] . Nevertheless,
ue to a high rate of false positive results secondary to other fac-
ors, the CDC recommends the QuantiFERON test for screening only
n patients who have been vaccinated with BCG or in those who are
nlikely to return for skin test reading [74] . In studies of healthcare
orkers screened with QuantiFERON testing, the false positive rate . (A) Preauricular lymphadenopathy. (B) Tarsal hypertrophy indicative of conjunctivitis 
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Fig. 6. Tuberculosis manifesting as a conjunctival nodule in a 26-year-old female [46] . 
w  
f
C
 
s  
h  
T  
i  
t  
T  
t
E
 
a  
a  
o  
r  
c
T
M
 
a  
t  
f  
m  
m  
a  
4  
d  
r  
c  
f  
g  
T  
i  
i  
t  
o  
b  
n
O
 
a  
s  
a  
a  
s  
o  
Fig. 7. Nodular scleritis caused by tuberculosis. (A) External photograph shows scle- 
ral nodules nasally and superiorly in the right eye. (B) Pathology and hematoxylin–
eosin staining reveals a mixed inﬂammatory inﬁltrate in the sclera consisting of lym- 
phocytes, plasma cells, and polymorphonuclear leukocytes with scleral necrosis. (C) A 
higher magniﬁcation of the hematoxylin–eosin stain reveals areas of scleral collagen 
necrosis [86] . 
Fig. 8. Tuberculous scleritis in a 52-year-old female [89] . 
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d  as as high as 41%, and a study of HIV-positive patients revealed a
alse positive rate of 80.5% in those at low risk for TB [75–78] . 
hest x-ray and computerized tomography 
Chest x-ray or computerized tomography of the chest demon-
trating cavities, consolidation, or lymph node enlargement should
eighten suspicion for primary TB infection [8] . Healed or reactivated
B lesions can also be observed, and any positive chest imaging ﬁnd-
ng should prompt sputum evaluation [79] . However, it is important
o keep in mind that ocular TB can occur in the absence of pulmonary
B, and the majority of chest radiographs may be normal in these pa-
ients [1,80] . 
xclusion of other causes and response to treatment 
It is always important to rule out other causes, such as syphilis
nd toxoplasmosis, when considering ocular TB [5] . Response to
nti-tuberculosis treatment (ATT) may be the ultimate conﬁrmation
f ocular TB, but care should be taken not to commit patients to the
equired long courses of treatment without ﬁrst ruling out other
auses [5,81] . 
reatment 
edical treatment 
Patients should be managed by both an ophthalmologist and
n infectious disease specialist, as systemic treatment is required
o manage ocular TB. Medical ATT for ocular TB is similar to that
or pulmonary TB; however, relapses of ocular TB are common and
ay require extended courses of treatment [57] . The CDC recom-
ends four-drug treatment with isoniazid, rifampin, pyrazinamide,
nd ethambutol for a total of 2 months, followed by an additional
–7 months of dual therapy with isoniazid and rifampin [82] . The
uration of therapy may be extended due to the typically slow
esponse in ocular TB or in cases of multi-drug resistance [13] . In
ases of multi-drug resistance or patient intolerance to any of the
our recommended agents, rifabutin, ﬂuoroquinolones, interferon
amma, and linezolid can also be of use [5] . In the past, ocular
B patients with latent TB received monotherapy in the form of
soniazid and/or rifampin rather than quadruple therapy; increas-
ngly, infectious disease specialists are recommending quadruple
herapy in part to reduce the development of multidrug resistant
rganisms [82] . Pyridoxine (vitamin B6) supplementation should
e used while patients are taking isoniazid to prevent peripheral
europathy [83] . 
cular side effects of medical therapy 
Patients should have a baseline eye exam prior to starting ATT
nd should be monitored for medication side effects, which can
ometimes be confused with worsening ocular TB [5] . Both isoniazid
nd ethambutol can cause optic neuropathy, commonly manifesting
s decreased visual acuity, decreased color vision, and/or cecocentral
cotomas [84] . Other known side effects of ethambutol include
ptic neuritis, red-green dyschromatopsia, disc edema, and optictrophy [5] . The development of these side effects should prompt
iscontinuation of the offending medication, as the side effects can
e reversible, with vision often returning to normal 10–15 weeks
fter drug cessation [5] . Vitamin B12 can also be used to help return
ision to normal, but in some cases vision loss may be permanent
5] . Rifabutin can cause anterior uveitis that typically responds well
o topical steroid treatment; very rarely, intermediate or panuveitis
as been reported in association with rifabutin [1] . 
onclusion 
TB is one of the great mimickers; thus ocular TB is often very
iﬃcult to diagnosis. TB can affect the orbit and external eye in a
56 L.A. Dalvin, W.M. Smith / Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 4 (2016) 50–57 
Fig. 9. A Ziehl–Neelsen stain reveals acid-fast bacilli, consistent with M. tuberculosis 
[87] . 
Fig. 10. A reactive Mantoux skin test is consistent with but not diagnostic of M. tuber- 
culosis infection [88] . 
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 wide variety of ways, and accurate diagnosis and treatment are cru-
cial to preventing permanent damage. Clinicians should maintain a
high index of suspicion, and ophthalmologists and infectious disease
specialists should work together in the treatment of ocular TB. 
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